Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
United States
Children's Hospital Los Angeles, Los Angeles, California Lucile Packard Children's Hospital, Palo Alto, California Washington University, St Louis, Missouri Nationwide Children's Hospital, Columbus, Ohio